Tue, May 11, 2021
Mon, May 10, 2021
Fri, May 7, 2021
Thu, May 6, 2021
Wed, May 5, 2021
Tue, May 4, 2021
Mon, May 3, 2021

Andrew Fein Maintained (UTHR) at Strong Buy with Increased Target to $248 on, May 6th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-248-on-may-6th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Fein of HC Wainwright & Co., Maintained "United Therapeutics Corporation" (UTHR) at Strong Buy with Increased Target from $195 to $248 on, May 6th, 2021.

Andrew has made no other calls on UTHR in the last 4 months.



There are 3 other peers that have a rating on UTHR. Out of the 3 peers that are also analyzing UTHR, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Andrew


  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $212 on, Thursday, April 8th, 2021
  • Martin Auster of "Credit Suisse" Maintained at Buy with Increased Target to $196 on, Monday, February 22nd, 2021
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $275 on, Tuesday, February 16th, 2021

Publication Contributing Sources